We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$164B
AUM Growth
+$11.8B
Cap. Flow
+$2.23B
Cap. Flow %
1.36%
Top 10 Hldgs %
25.88%
Holding
4,146
New
203
Increased
1,918
Reduced
1,677
Closed
157

Sector Composition

Rank Sector Weight
1 Technology 16.27%
2 Financials 8.92%
3 Healthcare 7.98%
4 Industrials 6.57%
5 Consumer Discretionary 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
3926
PUT
Amgen
AMGN
$211B
-4,300
Closed -$1.27M
AMTB icon
3927
Amerant Bancorp
AMTB
$1.18B
-9,505
Closed -$216K
ARQT icon
3928
Arcutis Biotherapeutics
ARQT
$3.52B
-21,631
Closed -$201K
BAK icon
3929
Braskem
BAK
$948M
-67,506
Closed -$435K
BBAR icon
3930
BBVA Argentina
BBAR
$3.85B
-42,536
Closed -$393K
BFC icon
3931
Bank First Corp
BFC
$1.68B
-9,012
Closed -$744K
BGX
3932
Blackstone Long-Short Credit Income Fund
BGX
$136M
-10,550
Closed -$131K
BKSY icon
3933
BlackSky Technology
BKSY
$892M
-1,945
Closed -$16.6K
BMBL icon
3934
Bumble
BMBL
$397M
-82,288
Closed -$865K
BMY icon
3935
CALL
Bristol-Myers Squibb
BMY
$130B
-43,000
Closed -$1.81M
BMY icon
3936
PUT
Bristol-Myers Squibb
BMY
$130B
-14,500
Closed -$609K
BRK.B icon
3937
PUT
Berkshire Hathaway Class B
BRK.B
$1.1T
-2,200
Closed -$869K
BTAI icon
3938
BioXcel Therapeutics
BTAI
$25.9M
-1,108
Closed -$22.7K
BVN icon
3939
Compañía de Minas Buenaventura
BVN
$7.72B
-27,280
Closed -$462K
BYND icon
3940
Beyond Meat
BYND
$276M
-217,963
Closed -$1.46M
CAF
3941
Morgan Stanley China A Share Fund
CAF
$330M
-52,071
Closed -$612K
CBRL icon
3942
Cracker Barrel
CBRL
$1.17B
-9,760
Closed -$412K
CCJ icon
3943
PUT
Cameco
CCJ
$37.7B
-9,700
Closed -$485K
CCRN
3944
DELISTED
Cross Country Healthcare
CCRN
-165,324
Closed -$2.29M
CFLT
3945
DELISTED
Confluent
CFLT
-22,200
Closed -$656K
CLMT icon
3946
Calumet Specialty Products
CLMT
$3.62B
-572,057
Closed -$9.18M
CMPS
3947
Compass Pathways
CMPS
$1.45B
-12,595
Closed -$76.1K
CMU
3948
DELISTED
MFS High Yield Municipal Trust
CMU
-11,415
Closed -$39.2K
COF icon
3949
PUT
Capital One
COF
$129B
-12,900
Closed -$1.48M
COOP
3950
DELISTED
Mr. Cooper
COOP
-2,961
Closed -$241K

Similar funds

Raymond James & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Raymond James & Associates held 4,146 positions worth $164B, up 7.7% from $152B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Raymond James & Associates's Q3 2024 filing shows 203 new, 1,918 increased, 1,677 reduced and 157 closed positions. Its largest new stake was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $516M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2024 buy was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M.
  • Raymond James & Associates added most to iShares Core S&P Mid-Cap ETF in Q3 2024, an estimated $520M increase.
  • Raymond James & Associates's biggest Q3 2024 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $516M.
  • Raymond James & Associates fully exited Ferguson in Q3 2024, selling an estimated $63.3M.
  • Raymond James & Associates's ten largest holdings make up 26% of its $164B portfolio in Q3 2024.
  • Raymond James & Associates opened 203 new positions and closed 157 in Q3 2024.
  • Raymond James & Associates's portfolio value rose 7.7% quarter-over-quarter to $164B.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.